newsfilter
← Latest News
GlobeNewswire·

Reunion Neuroscience Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ:REUN, TSX:REUN) ("Reunion" or "the Company"), a clinical-stage biopharmaceutical company committed to developing innovative and patented